75 Results for "

Platinum

" in MedChemExpress (MCE) Product Catalog:
Products (75)

75 Results for "Platinum" in MCE Product Catalog:

837
837 Publications Verification
Cat. No.: HY-17394
CAS No.: 15663-27-1
Synonyms: cis-Platinum; CDDP; cis-DiaminodichloroPlatinum
Cisplatin (CDDP) is an antineoplastic chemotherapy agent by cross-linking with DNA and causing DNA damage in cancer cells. Cisplatin activates ferroptosis and induces autophagy .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-105930
CAS No.: 135558-11-1
Purity:  ≥98.0%
Synonyms: D-19466
Research Areas:  

Cancer

Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexe. Lobaplatin arrests cell cycle at G1 and G2/M phase. Lobaplatin induces apoptosis by increasing expressions of caspase and Bax, decreasing expression of Bcl-2. Lobaplatin can be used for research of cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114842
CAS No.: 1644626-43-6
Purity:  99.84%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

TDRL-551 is a potent replication protein A (RPA) inhibitor (IC50 = 18 µM). TDRL-551 inhibits RPA-DNA interaction and increases the anti-cancer efficacy of Platinum (Pt)-based chemotherapy. TDRL-551 can be used for the research of cancer, such as non-small cell lung cancer (NSCLC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1022
CAS No.: 16208-51-8
Synonyms: BNP-7787
Target:  

Drug Derivative

Research Areas:  

Endocrinology Cancer

Dimesna (BNP-7787), the disulfide form of Mesna (HY-13679), is a platinum-related toxicity protective agent. Dimesna converts to Mesna, which in turn inactivates toxic platinum substances. Dimesna does not interfere with the antitumor activity of platinum compounds. Dimesna does not affect the antiproliferative effects of Cisplatin (HY-17394) or Carboplatin (HY-17393). Dimesna counteracts Cisplatin-induced nephrotoxicity. Dimesna exerts selective protective effects on the kidneys. Dimesna can be used in studies related to ovarian cancer and Cisplatin-induced nephrotoxicity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W007712
CAS No.: 3430-17-9
Synonyms: 2-Bromo-3-picoline
2-Bromo-3-methylpyridine (2-Bromo-3-picoline) is a heterocyclic intermediate of the halomethylpyridine family. 2-Bromo-3-methylpyridine can be used in the synthesis of platinum(IV) diazide complexes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P11050
CAS No.: 1309883-67-7
Target:  

Peptides

Research Areas:  

Cancer

SP94 peptide, Cys conjugated is a hepatocellular carcinoma (HCC)-targeting peptide conjugated with Cys. SP94 peptide, Cys conjugated can be used for synthesis of stimuli-responsive peptide nanomaterials (SRPNs) like platinum nanocluster assemblies (PT-NA) and it promotes the entry of PT-NA into HCC cells by mediating endocytosis. SP94 peptide, Cys conjugated can be used for cancers research .
loading...
    loading...
Cat. No.: HY-Y0091
CAS No.: 161265-03-8
Synonyms: 9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene
Xantphos (9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene) is a bisphosphine ligand. Xantphos coordinates to metals in either cis or trans chelation mode. Xantphos acts as a key ligand in palladium or platinum catalyzed reactions. Xantphos can be used in the construction of heterocyclic compounds in organic synthesis .
loading...
    loading...
Cat. No.: HY-P991628
Synonyms: PF-08634404

Target:  

PD-1/PD-L1 VEGFR

Research Areas:  

Cancer

SSGJ-707 (PF-08634404) is a bispecific antibody targeting VEGF and PD-1. SSGJ-707 exerts dual anti-tumor effects by neutralizing VEGF and blocking the PD-1 signaling pathway. SSGJ-707 can be combined with platinum-based chemotherapy to inhibit advanced non-small cell lung cancer (NSCLC), and its inhibitory effect is not limited by PD-L1 expression levels. In the HARMONi-2 trial, the objective response rate of SSGJ-707 correlates with the PD-L1 tumor proportion score, and the incidence of grade ≥3 adverse events is comparable to that of Inetetamab (HY-P99969). SSGJ-707 is being extensively investigated for a variety of malignancies including advanced NSCLC, colorectal cancer and small cell lung cancer .
loading...
    loading...
Cat. No.: HY-109146
CAS No.: 1339960-28-9
Purity:  ≥95.0%
Synonyms: PT-112
Research Areas:  

Cancer

Imifoplatin (PT-112) is a platinum-based active molecule and a member of the phosphaplatins family. Imifoplatin can induce Apoptosis and exhibits antitumor activity .
loading...
    loading...
Cat. No.: HY-126061
CAS No.: 33868-03-0
Purity:  99.82%
1,7-Dimethyluric acid is an N-methylated uric acid and purine derivative, as well as a caffeine metabolite. When 1,7-Dimethyluric acid is acted upon by peroxidase in the presence of H2O2, it follows the same oxidation pathway to generate a UV-absorbing intermediate, which decays via first-order kinetics. 1,7-Dimethyluric acid can adsorb onto pyrolytic graphite electrodes, but not onto glassy carbon electrodes or platinum electrodes. The N-methylation modification of its pyrimidine ring prevents ring contraction of the diol intermediate, and no NMR evidence of O-alkylation is observed during propylation under the test conditions .
loading...
    loading...
Cat. No.: HY-112030
CAS No.: 10025-99-7
Purity:  ≥98.0%
Synonyms: Potassium tetrachloroplatinate(Ⅱ)
Research Areas:  

Cancer

Dipotassium tetrachloroplatinate (Potassium tetrachloroplatinate (Ⅱ)) is an important reagent for the preparation of other platinum coordination complexes. Dipotassium tetrachloroplatinate acts as a radiosensitizer to enhance the killing effect of hyperthermia. Dipotassium tetrachloroplatinate serves as a catalyst. Dipotassium tetrachloroplatinate exhibits antitumor activity .
loading...
    loading...
Cat. No.: HY-P990651

Target:  

TREM receptor

Research Areas:  

Cancer

PY314 is a humanized antibody targeting TREM2. PY314 binds TREM2 on tumor-associated macrophages, depletes TREM2-high tumor-associated macrophages, reduces pro-tumorigenic M2 macrophage infiltration, increases CD8 + T cell, NK cell, and M1 macrophage infiltration, creates a proinflammatory tumor microenvironment, and promotes antitumor immune responseS. PY314 can be used for the research of platinum-resistant ovarian cancer, advanced solid tumors, breast cancer, and advanced refractory solid tumors .
loading...
    loading...
Cat. No.: HY-16129
CAS No.: 565434-85-7
CBP-501, a cell-permeable calmodulin-binding peptide and a G2-abrogating drug candidate, inhibits the activity of multiple Ser 216-specific kinases, such as MAPKAP-K2, C-Tak1, CHK1 and CHK2, with IC50 values of 0.9 μM, 1.4 μM 3.4 μM and 6.5 μM, respectively. CBP-501 is used for various types of cancer .
loading...
    loading...
Cat. No.: HY-P99705
CAS No.: 1401812-88-1
Synonyms: RG-7599; DNIB-0600A; NaPi2b-ADC
Research Areas:  

Cancer

Lifastuzumab vedotin (RG-7599; DNIB0600A) is an antibody-drug conjugate (ADC) that comprises a humanized IgG1 anti-NaPi2b monoclonal antibody (MNIB2126A) and a potent antimitotic agent, monomethyl auristatin E (MMAE), which inhibits cell division by blocking the polymerization of tubulin. Lifastuzumab vedotin has the potential for non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC) research .
loading...
    loading...
Cat. No.: HY-W096169D
CAS No.: 7440-06-4
Platinum is a metallic element, and its complexes act as orally active anticancer agents. Platinum-based complexes used for tumors include Cisplatin (HY-17394), Carboplatin (HY-17393), and Oxaliplatin (HY-17371) .
loading...
    loading...
Cat. No.: HY-W034985
CAS No.: 14221-02-4
Synonyms: Tetrakis(triphenylphosphine)Platinum(0)
Tetrakis(triphenylphosphine)platinum is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
loading...
    loading...
Cat. No.: HY-W075885
CAS No.: 14913-33-8
Synonyms: trans-Platinumdiamminedichloride
trans-Platinum(II)diammine dichloride (trans-platinumdiamminedichloride) is a geometric isomer of Cisplatin (HY-17394). Trans-Platinum(II)diammine dichloride is a DNA cross-linking agent that induces significant DNA cross-link damage while exhibiting low cytotoxicity. Trans-Platinum(II)diammine dichloride is useful for studying DNA-protein cross-links .
loading...
    loading...
Cat. No.: HY-131468
CAS No.: 181630-15-9
Purity:  98.5%
Synonyms: AMD473; ZD0473
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

Picoplatin (AMD473) is a platinum-based antineoplastic agent. Picoplatin is specifically to circumvent thiol-mediated drug resistance by sterically hindering its reaction with glutathione (GSH) while still retaining the ability to form cytotoxic lesions with DNA .
loading...
    loading...
Cat. No.: HY-162133
CAS No.: 3028778-96-0
Research Areas:  

Cancer

MSA-2-Pt, platinum salt-modified MSA-2 (HY-136927), is a STING agonist. MSA-2-Pt inducing cell
death by platinum and activating the STING pathway by MSA-2. MSA-2-Pt direct activates STING pathway, induces phosphorylation of TBK1, IRF3, and NF-κB p65. MSA-2-Pt enhances tumor infiltration of CD4 + and CD8 + T cells, and induces tumor cell death and apoptosis in mouse colon carcinoma and melanoma models .
loading...
    loading...
Cat. No.: HY-P990650

Target:  

TREM receptor

Research Areas:  

Cancer

PY159 is a humanized antibody targeting TREM1/CD354. PY159 reprograms immunosuppressive intratumoral myeloid cells towards an inflammatory, anti-tumor phenotype, promotes anti-tumor immune responses, upregulates monocyte activation markers, and induces proinflammatory cytokines. PY159 can be used for the research of platinum-resistant ovarian cancer, advanced solid tumors, and advanced refractory solid tumors .
loading...
    loading...